Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedNew user-facing sections have been added, including No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, to guide potential participants. The labeling and version metadata have been updated (Intervention/Treatment and Revision: v3.6.0) signaling a formatting change and a refreshed page revision.SummaryDifference0.6%

- Check9 days agoChange DetectedRevision bumped from v3.5.4 to v3.5.5, indicating a new published release of the page. This change does not affect the study details or functionality.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision tag v3.5.4 has been added, replacing the previous v3.5.3, indicating a software release update for the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page’s revision/version indicator updates from v3.5.2 to v3.5.3, reflecting a publishing or site release change without affecting the study record content.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.